Latest News & Features
Americas
While cannabis companies in the US can’t protect their brands with federal trademark protection, there are other options for them when seeking IP rights, as LSIPR finds out. 24 October 2018
Americas
The implementation of precision medicine represents a huge, possibly unprecedented, challenge to conventional clinical practice across the breadth of healthcare disciplines, says Daniel Lim of Kirkland & Ellis. 23 October 2018
Americas
Maryland-based United Therapeutics has inked a licence, development and commercialisation agreement with CollPlant, an Israeli biotech company, for 3D bioprinted lung transplants. 23 October 2018
Americas
In a blow to Allergan and the Saint Regis Mohawk Tribe, the US Court of Appeals for the Federal Circuit yesterday refused to reconsider an earlier decision that rejected use of tribal sovereign immunity in inter partes reviews. 23 October 2018
Biotechnology
An EU court ruling on gene-editing regulation has sparked widespread concerns in the scientific and legal communities, as LSIPR finds out. 22 October 2018
Americas
Novartis is planning to acquire Endocyte, an Indiana-based biotech, to accelerate its development of radiopharmaceuticals. 22 October 2018
Americas
AbbVie has announced that it has entered into a licensing deal with Germany-based pharmaceutical company Fresenius Kabi. 22 October 2018
Americas
Amgen has invested £50 million ($66 million) in Oxford Nanopore Technologies, a UK company specialising in DNA/RNA sequencing technology. 19 October 2018
Americas
Non-profit organisation I-MAK is waging a global challenge against what it sees as invalid pharmaceutical patents, with access to life-saving drugs its main priority. LSIPR speaks to co-founder Tahir Amin to find out more. 19 October 2018
Big Pharma
The supplementary protection certificate manufacturing waiver “sends a worrying global signal that the EU is weakening its IP framework”, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA). 18 October 2018